Octopus backs drug discovery

UK early-stage investor Octopus Ventures has made a £2m investment in e-Therapeutics, a Newcastle-based drug discovery business.

The company specializes in reducing the time a medicine takes between discovery and commercialization by using its unique technology to asses drug candidates for high efficacy and safety ahead of clinical trials.

This latest round of funding by Octopus comes after a 2007 round, also led by Octopus, which came shortly before the company listed on London’s AIM.